CIK 0001770121
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sana Biotechnology, Inc.
Sign in to watch- Ticker
- SANA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831381173
- Phone
- +1 206-701-7914
- Business address
- 188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-05 | NELSEN ROBERT Director | Grant or award | +266 | 496 | ||
| 2022-06-13 | MacDonald James J. EVP & General Counsel | Option exercise | +66,796 | $1.48 | $99K | 497,396 |
| 2022-06-13 | MacDonald James J. EVP & General Counsel | Option exercise · Stock Option (Right to Buy) | −66,796 | 51,954 | ||
| 2022-06-06 | REICIN ALISE Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2022-06-06 | Bilenker Joshua H. Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2022-06-06 | Seitz Michelle Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2022-06-06 | Wilderotter Mary Agnes Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2022-06-06 | Cole Douglas G. Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2022-06-06 | Yang Patrick Y Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2022-06-06 | Bishop Hans Edgar Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2022-06-06 | NELSEN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2022-05-13 | MacDonald James J. EVP & General Counsel | Grant or award | +1,183 | $4.28 | $5K | 430,600 |
| 2022-04-05 | Bishop Hans Edgar Director | Grant or award | +2,880 | 5,739,130 | ||
| 2022-04-05 | NELSEN ROBERT Director | Grant or award | +230 | 230 | ||
| 2022-03-21 | Yang Patrick Y Director | Purchase | +28,000 | $7.30 | $204K | 174,250 |
| 2022-03-03 | Harr Steve President & CEO | Grant or award · Stock Options (Right to Buy) | +760,000 | 760,000 | ||
| 2022-03-03 | AGARWAL SUNIL EVP, Head of Development & CMO | Grant or award · Stock Options (Right to Buy) | +250,000 | 250,000 | ||
| 2022-03-03 | Mulligan Richard Head of SanaX | Grant or award · Stock Options (Right to Buy) | +250,000 | 250,000 | ||
| 2022-03-03 | Hordo Christian EVP, Chief Business Officer | Grant or award · Stock Options (Right to Buy) | +225,000 | 225,000 | ||
| 2022-03-03 | MacDonald James J. EVP & General Counsel | Grant or award · Stock Options (Right to Buy) | +225,000 | 225,000 |
Page 10 of 16 · 315 trades